Literature DB >> 5958625

[Effect of INH therapy on tuberculous lesions developing during blocking of the reticulo-histiocytic system].

A Eskenasy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5958625

Source DB:  PubMed          Journal:  Med Thorac        ISSN： 0368-9220


× No keyword cloud information.
  14 in total

Review 1.  Tau proteins in blood as biomarkers of Alzheimer's disease and other proteinopathies.

Authors:  Federico Verde
Journal:  J Neural Transm (Vienna)       Date:  2022-02-17       Impact factor: 3.575

2.  Deep Sea Water Alleviates Tau Phosphorylation and Cognitive Impairment via PI3K/Akt/GSK-3β Pathway.

Authors:  Shan He; Wei-Bing Peng; Xian-Jun Fu; Hong-Lei Zhou; Zhen-Guo Wang
Journal:  Mar Biotechnol (NY)       Date:  2022-01-04       Impact factor: 3.619

Review 3.  An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders.

Authors:  Nicholas J Ashton; Abdul Hye; Anto P Rajkumar; Antoine Leuzy; Stuart Snowden; Marc Suárez-Calvet; Thomas K Karikari; Michael Schöll; Renaud La Joie; Gil D Rabinovici; Kina Höglund; Clive Ballard; Tibor Hortobágyi; Per Svenningsson; Kaj Blennow; Henrik Zetterberg; Dag Aarsland
Journal:  Nat Rev Neurol       Date:  2020-04-22       Impact factor: 42.937

4.  Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease.

Authors:  Zhiwu Dong; Hongjun Gu; Qiang Guo; Shuang Liang; Jian Xue; Feng Yao; Xianglu Liu; Feifei Li; Huiling Liu; Li Sun; Kewen Zhao
Journal:  Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.590

Review 5.  Microglia Biomarkers in Alzheimer's Disease.

Authors:  Peng-Fei Zhang; Hao Hu; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2021-03-12       Impact factor: 5.590

6.  Grey zone amyloid burden affects memory function: the SCIENCe project.

Authors:  J L Ebenau; S C J Verfaillie; K A van den Bosch; T Timmers; L M P Wesselman; M van Leeuwenstijn; H Tuncel; S V S Golla; M M Yaqub; A D Windhorst; N D Prins; F Barkhof; P Scheltens; W M van der Flier; B N M van Berckel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09-04       Impact factor: 9.236

7.  Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population.

Authors:  Qiu-Yue Dong; Tao-Ran Li; Xue-Yan Jiang; Xiao-Ni Wang; Ying Han; Jie-Hui Jiang
Journal:  Alzheimers Res Ther       Date:  2021-04-07       Impact factor: 6.982

8.  Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.

Authors:  Shorena Janelidze; Niklas Mattsson; Sebastian Palmqvist; Ruben Smith; Thomas G Beach; Geidy E Serrano; Xiyun Chai; Nicholas K Proctor; Udo Eichenlaub; Henrik Zetterberg; Kaj Blennow; Eric M Reiman; Erik Stomrud; Jeffrey L Dage; Oskar Hansson
Journal:  Nat Med       Date:  2020-03-02       Impact factor: 53.440

9.  Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease.

Authors:  Shorena Janelidze; Erik Stomrud; Ruben Smith; Sebastian Palmqvist; Niklas Mattsson; David C Airey; Nicholas K Proctor; Xiyun Chai; Sergey Shcherbinin; John R Sims; Gallen Triana-Baltzer; Clara Theunis; Randy Slemmon; Marc Mercken; Hartmuth Kolb; Jeffrey L Dage; Oskar Hansson
Journal:  Nat Commun       Date:  2020-04-03       Impact factor: 14.919

10.  Classification of negative and positive 18F-florbetapir brain PET studies in subjective cognitive decline patients using a convolutional neural network.

Authors:  Bart Marius de Vries; Sandeep S V Golla; Jarith Ebenau; Sander C J Verfaillie; Tessa Timmers; Fiona Heeman; Matthijs C F Cysouw; Bart N M van Berckel; Wiesje M van der Flier; Maqsood Yaqub; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09-02       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.